STOCK TITAN

[Form 4] CODEXIS, INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Codexis (CDXS) reported an insider transaction by its Chief Financial Officer, Georgia Erbez. On 10/13/2025, she sold 6,239 shares of common stock at $2.505 per share. The filing notes the sale was made solely to satisfy tax or other government withholding obligations tied to the vesting of Restricted Stock Units.

Following the transaction, Erbez beneficially owned 70,636 shares directly, which includes 33,333 RSUs. The transaction code was listed as S, indicating a sale.

Codexis (CDXS) ha riportato una transazione interna del suo Chief Financial Officer, Georgia Erbez. Il 13/10/2025 ha venduto 6.239 azioni ordinarie a $2,505 per azione. La comunicazione specifica che la vendita è stata effettuata unicamente per soddisfare obblighi fiscali o altri oneri governativi legati al vesting di unità azione limitate soggette a restrizioni (RSU).

Dopo la transazione, Erbez deteneva direttamente 70.636 azioni, che incluiscono 33.333 RSU. Il codice della transazione è stato indicato come S, che indica una vendita.

Codexis (CDXS) reportó una operación interna de su directora financiera, Georgia Erbez. El 13/10/2025, vendió 6,239 acciones comunes a $2.505 por acción. El filing indica que la venta se realizó únicamente para satisfacer obligaciones fiscales u otros gravámenes gubernamentales vinculados al vesting de las Unidades de Acciones Restringidas (RSU).

Tras la operación, Erbez poseía de forma beneficiosa 70,636 acciones directamente, lo que incluye 33,333 RSU. El código de la operación fue registrado como S, lo que indica una venta.

Codexis (CDXS)가 최고재무책임자 Georgia Erbez의 내부 거래를 보고했습니다. 2025년 10월 13일, 그녀는 6,239주의 보통주를 주당 $2,505에 매도했습니다. 서류상 이 매도는 RSU의 가속 vesting과 관련된 세금 또는 기타 정부 withholding 의무를 충족하기 위한 것이라고 명시되어 있습니다.

거래 후 Erbez는 직접 70,636주를 이익 소유하게 되었으며, 이 중 33,333 RSU를 포함합니다. 거래 코드는 S로 기재되어 매도를 나타냅니다.

Codexis (CDXS) a annoncé une opération d'initié de son directeur financier, Georgia Erbez. Le 13/10/2025, elle a vendu 6 239 actions ordinaires à 2,505 $ par action. Le dépôt précise que la vente a été réalisée uniquement pour satisfaire les obligations fiscales ou d'autres retenues gouvernementales liées à l'acquisition des unités d'actions restreintes (RSU).

Suite à la transaction, Erbez détenait directement 70 636 actions , ce qui inclut 33 333 RSU. Le code de la transaction était répertorié comme S, indiquant une vente.

Codexis (CDXS) meldete eine Insider-Transaktion ihrer Chief Financial Officer, Georgia Erbez. Am 13.10.2025 verkaufte sie 6.239 Aktien Stammaktien zu 2,505 $ pro Aktie. Die Einreichung vermerkt, dass der Verkauf ausschließlich erfolgt sei, um Steuer- oder andere staatliche Abzugsverpflichtungen im Zusammenhang mit dem Vesting von Restricted Stock Units (RSUs) zu erfüllen.

Nach der Transaktion besaß Erbez direkt 70.636 Aktien, was einschließt 33.333 RSUs. Der Transaktionscode war als S aufgeführt und deutet auf einen Verkauf hin.

Codexis (CDXS) أبلغت عن صفقة داخلية من قبل المدير المالي لها، جورجيا إيربـز. في 13/10/2025، باعت 6,239 سهماً عاديًا بسعر $2.505 للسهم الواحد. تشير الوثيقة إلى أن البيع تم فقط لتلبية الالتزامات الضريبية أو استقطاعات حكومية أخرى مرتبطة بعملية vesting للوحدات الأسهم المقيدة (RSU).

بعد الصفقة، أصبحت إيربـز مالكاً فعلياً لـ 70,636 سهماً مباشرة، والتي تشمل 33,333 RSU. تم تسجيل رمز الصفقة كـ S، مما يشير إلى بيع.

Codexis (CDXS) 报告其首席财务官 Georgia Erbez 的内部交易。2025年10月13日,她以每股 $2.505 的价格出售了 6,239股 普通股。 filings 表示该出售仅为满足与限制性股票单位(RSU)归属相关的税务或其他政府扣缴义务。

交易结束后,Erbez直接实际拥有70,636股,其中含有33,333RSU。该交易代码被列为S,表示卖出。

Positive
  • None.
Negative
  • None.

Codexis (CDXS) ha riportato una transazione interna del suo Chief Financial Officer, Georgia Erbez. Il 13/10/2025 ha venduto 6.239 azioni ordinarie a $2,505 per azione. La comunicazione specifica che la vendita è stata effettuata unicamente per soddisfare obblighi fiscali o altri oneri governativi legati al vesting di unità azione limitate soggette a restrizioni (RSU).

Dopo la transazione, Erbez deteneva direttamente 70.636 azioni, che incluiscono 33.333 RSU. Il codice della transazione è stato indicato come S, che indica una vendita.

Codexis (CDXS) reportó una operación interna de su directora financiera, Georgia Erbez. El 13/10/2025, vendió 6,239 acciones comunes a $2.505 por acción. El filing indica que la venta se realizó únicamente para satisfacer obligaciones fiscales u otros gravámenes gubernamentales vinculados al vesting de las Unidades de Acciones Restringidas (RSU).

Tras la operación, Erbez poseía de forma beneficiosa 70,636 acciones directamente, lo que incluye 33,333 RSU. El código de la operación fue registrado como S, lo que indica una venta.

Codexis (CDXS)가 최고재무책임자 Georgia Erbez의 내부 거래를 보고했습니다. 2025년 10월 13일, 그녀는 6,239주의 보통주를 주당 $2,505에 매도했습니다. 서류상 이 매도는 RSU의 가속 vesting과 관련된 세금 또는 기타 정부 withholding 의무를 충족하기 위한 것이라고 명시되어 있습니다.

거래 후 Erbez는 직접 70,636주를 이익 소유하게 되었으며, 이 중 33,333 RSU를 포함합니다. 거래 코드는 S로 기재되어 매도를 나타냅니다.

Codexis (CDXS) a annoncé une opération d'initié de son directeur financier, Georgia Erbez. Le 13/10/2025, elle a vendu 6 239 actions ordinaires à 2,505 $ par action. Le dépôt précise que la vente a été réalisée uniquement pour satisfaire les obligations fiscales ou d'autres retenues gouvernementales liées à l'acquisition des unités d'actions restreintes (RSU).

Suite à la transaction, Erbez détenait directement 70 636 actions , ce qui inclut 33 333 RSU. Le code de la transaction était répertorié comme S, indiquant une vente.

Codexis (CDXS) meldete eine Insider-Transaktion ihrer Chief Financial Officer, Georgia Erbez. Am 13.10.2025 verkaufte sie 6.239 Aktien Stammaktien zu 2,505 $ pro Aktie. Die Einreichung vermerkt, dass der Verkauf ausschließlich erfolgt sei, um Steuer- oder andere staatliche Abzugsverpflichtungen im Zusammenhang mit dem Vesting von Restricted Stock Units (RSUs) zu erfüllen.

Nach der Transaktion besaß Erbez direkt 70.636 Aktien, was einschließt 33.333 RSUs. Der Transaktionscode war als S aufgeführt und deutet auf einen Verkauf hin.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Erbez Georgia

(Last) (First) (Middle)
C/O CODEXIS, INC.
200 PENOBSCOT DRIVE

(Street)
REDWOOD CITY CA 94063

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CODEXIS, INC. [ CDXS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/13/2025 S(1) 6,239 D $2.505 70,636(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units ("RSUs") of the Issuer.
2. Includes 33,333 restricted stock units.
/s/ Georgia Erbez 10/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Codexis (CDXS) disclose in this Form 4?

The CFO, Georgia Erbez, reported selling 6,239 shares on 10/13/2025 at $2.505 per share.

Why were the CDXS shares sold by the CFO?

The filing states the sale was solely to satisfy tax or other government withholding obligations related to RSU vesting.

How many shares does the Codexis CFO own after the sale?

She beneficially owned 70,636 shares directly after the transaction.

How many RSUs are included in the CFO’s holdings?

Her holdings include 33,333 restricted stock units (RSUs).

What was the transaction code on the Form 4?

The transaction code was S, indicating a sale.

What is the issuer and ticker in this filing?

The issuer is Codexis, Inc. with ticker CDXS.
Codexis Inc

NASDAQ:CDXS

CDXS Rankings

CDXS Latest News

CDXS Latest SEC Filings

CDXS Stock Data

249.14M
87.93M
2.28%
80.74%
5.54%
Biotechnology
Industrial Organic Chemicals
Link
United States
REDWOOD CITY